scholarly article | Q13442814 |
P50 | author | Andreas Ludwig | Q37378631 |
Seung-Taek Lee | Q38523952 | ||
Won-Sik Shin | Q55069759 | ||
P2093 | author name string | Hye-Won Na | |
P2860 | cites work | The many roles of PTK7: A versatile regulator of cell–cell communication | Q21710722 |
A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions | Q24294366 | ||
The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis. | Q24299587 | ||
The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion | Q24300435 | ||
Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family | Q24303539 | ||
Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling | Q24306299 | ||
Protein tyrosine kinase 7 has a conserved role in Wnt/β-catenin canonical signalling | Q24313083 | ||
Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2 | Q24607154 | ||
A phosphatase associated with metastasis of colorectal cancer | Q28198115 | ||
The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs | Q28215674 | ||
A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes | Q28256848 | ||
Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain | Q28266755 | ||
Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain | Q28273268 | ||
Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach | Q28276398 | ||
The ADAM metalloproteinases | Q28292696 | ||
Cloning and characterization of the full-length mouse Ptk7 cDNA encoding a defective receptor protein tyrosine kinase | Q28509449 | ||
PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates | Q28587777 | ||
An intramolecular interaction between SH2-kinase linker and kinase domain is essential for the catalytic activity of protein-tyrosine kinase-6. | Q30160209 | ||
Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondrial pathway | Q33754728 | ||
Dtrk, a Drosophila gene related to the trk family of neurotrophin receptors, encodes a novel class of neural cell adhesion molecule | Q33937330 | ||
Characterization of the human full-length PTK7 cDNA encoding a receptor protein tyrosine kinase-like molecule closely related to chick KLG. | Q34403860 | ||
Transmodulation of cell surface regulatory molecules via ectodomain shedding | Q34584816 | ||
Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis. | Q34761951 | ||
Global gene expression profiling and validation in esophageal squamous cell carcinoma and its association with clinical phenotypes | Q34917292 | ||
Intramembrane-cleaving proteases: controlled liberation of proteins and bioactive peptides | Q35057311 | ||
The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer? | Q35206311 | ||
ADAM17 mRNA expression and pathological features of hepatocellular carcinoma | Q36065819 | ||
Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. | Q36074351 | ||
Shedding light on ADAM metalloproteinases | Q36159565 | ||
Substrate specificity of gamma-secretase and other intramembrane proteases | Q37073568 | ||
Identification of ligand-induced proteolytic cleavage and ectodomain shedding of VEGFR-1/FLT1 in leukemic cancer cells | Q37173281 | ||
The ADAMs: signalling scissors in the tumour microenvironment | Q37324256 | ||
The "a disintegrin and metalloprotease" (ADAM) family of sheddases: physiological and cellular functions | Q37339450 | ||
Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer | Q37412311 | ||
The many substrates of presenilin/γ-secretase | Q37845036 | ||
PTK7 recruits dsh to regulate neural crest migration | Q38359072 | ||
PTK7/Otk interacts with Wnts and inhibits canonical Wnt signalling | Q38441808 | ||
The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome | Q39691348 | ||
Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach | Q39772828 | ||
ADAM-17 expression in breast cancer correlates with variables of tumor progression. | Q40145085 | ||
Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma | Q40230508 | ||
Multiple acquired renal carcinoma tumor capabilities abolished upon silencing of ADAM17. | Q40243306 | ||
Up-regulated expression of ADAM17 in human colon carcinoma: co-expression with EGFR in neoplastic and endothelial cells | Q40393668 | ||
Increased expression of ADAM family members in human breast cancer and breast cancer cell lines | Q40487746 | ||
Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. | Q40528644 | ||
Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas | Q40628094 | ||
PlexinA1 interacts with PTK7 and is required for neural crest migration | Q42858898 | ||
High-throughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targets | Q44772602 | ||
The membrane proteases adams and hepsin are differentially expressed in renal cell carcinoma. Are they potential tumor markers? | Q45147208 | ||
Novel regions of chromosomal amplification at 6p21, 5p13, and 12q14 in gastric cancer identified by array comparative genomic hybridization | Q45196334 | ||
The transmembrane protein Off-track associates with Plexins and functions downstream of Semaphorin signaling during axon guidance | Q46324780 | ||
Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis | Q46601425 | ||
RACK1 is a novel interaction partner of PTK7 that is required for neural tube closure | Q46835728 | ||
Differential inhibition of membrane type 3 (MT3)-matrix metalloproteinase (MMP) and MT1-MMP by tissue inhibitor of metalloproteinase (TIMP)-2 and TIMP-3 rgulates pro-MMP-2 activation. | Q47846803 | ||
Transformation of mammalian cells with genes from prokaryotes and eukaryotes. 1979. | Q49011297 | ||
TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3 | Q77357145 | ||
P433 | issue | 30 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell migration | Q189092 |
colon cancer | Q18555025 | ||
P304 | page(s) | 25001-25009 | |
P577 | publication date | 2012-06-04 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | The cytosolic domain of protein-tyrosine kinase 7 (PTK7), generated from sequential cleavage by a disintegrin and metalloprotease 17 (ADAM17) and γ-secretase, enhances cell proliferation and migration in colon cancer cells | |
P478 | volume | 287 |
Q47112549 | Antibody-drug conjugate targeting protein tyrosine kinase 7, a receptor tyrosine kinase-like molecule involved in WNT and vascular endothelial growth factor signaling: effects on cancer stem cells, tumor microenvironment and whole-body homeostasis |
Q37687371 | Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells |
Q39016511 | Downstream signaling and genome-wide regulatory effects of PTK7 pseudokinase and its proteolytic fragments in cancer cells. |
Q39162354 | Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases. |
Q48087924 | Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics. |
Q91239717 | Gamma-secretase-dependent signaling of receptor tyrosine kinases |
Q47989436 | Genome-wide screen of gamma-secretase-mediated intramembrane cleavage of receptor tyrosine kinases. |
Q37500185 | Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growth |
Q47391313 | Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene |
Q36451958 | Insights into ectodomain shedding and processing of protein-tyrosine pseudokinase 7 (PTK7) |
Q36324512 | Matrix metalloproteinases - From the cleavage data to the prediction tools and beyond |
Q39153742 | Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma. |
Q35593473 | Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer |
Q37444908 | PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement |
Q48220908 | PTK6 Localized at the Plasma Membrane Promotes Cell Proliferation and MigratiOn Through Phosphorylation of Eps8. |
Q92271121 | PTK7 proteolytic fragment proteins function during early Xenopus development |
Q30586597 | Protein-tyrosine pseudokinase 7 (PTK7) directs cancer cell motility and metastasis |
Q36113481 | Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases |
Q26738712 | Ptk7 and Mcc, Unfancied Components in Non-Canonical Wnt Signaling and Cancer |
Q26830216 | Receptor tyrosine kinases in the nucleus |
Q30411399 | Simultaneous profiling of 194 distinct receptor transcripts in human cells |
Q34981717 | The Coxsackievirus and Adenovirus Receptor (CAR) undergoes ectodomain shedding and regulated intramembrane proteolysis (RIP). |
Q36381975 | The PTK7 and ROR2 Protein Receptors Interact in the Vertebrate WNT/Planar Cell Polarity (PCP) Pathway. |
Q38690911 | Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors |
Q29615666 | WNT signalling pathways as therapeutic targets in cancer |
Q50421596 | miR‑205‑5p/PTK7 axis is involved in the proliferation, migration and invasion of colorectal cancer cells |
Search more.